FUJIFILM Holdings Corp

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

FUJIFILM Holdings, Inc. engages in the development, production, sales and service of imaging, information, and document solutions. It operates through the following segments: Healthcare, Materials Solutions, Business Innovation and Imaging Solutions. The Healthcare segment provides medical system equipment, contract manufacturing and development of bio pharmaceuticals and drug discovery support materials. The Materials Solutions segment offers electronic materials, display materials, industrial equipment, fine chemicals, recording media, graphic communication system equipment and inkjet equipment. The Business Innovation segment offers digital multi function devices, solutions and services. The Imaging Solutions segment handles color films, digital cameras, optical devices, color paper, services and equipment for photofinishing, and instant photo systems. The company was founded on January 20, 1934 and is headquartered in Tokyo, Japan.

FUJIY advances global health with the NURA Global Innovation Center in India, combining health screenings, medical staff training and remote image analysis.

FUJIFILM Expands Health Screening Services With NURA Center in India

With ASPIRE Cristalle AWS, organizations within the DoD network will be able to securely acquire and access patients' mammography images With ASPIRE Cristalle AWS, organizations within the DoD network will be able to securely acquire and access patients' mammography images

Fujifilm Granted Authority to Operate its ASPIRE Cristalle Aquisition Workflow System (AWS) on U.S. Department of Defense Networks

New presses enable customers to utilize vibrant print applications to enhance productivity through Fujifilm's next generation technology New presses enable customers to utilize vibrant print applications to enhance productivity through Fujifilm's next generation technology

Fujifilm Introduces New REVORIA PRESS Products with Available Specialty Color Capabilities

Synapse PACS' Viewer eXtension's (VX) powerful speed helps increase productivity and diagnostic confidence for both the inpatient and outpatient markets Synapse PACS' Viewer eXtension's (VX) powerful speed helps increase productivity and diagnostic confidence for both the inpatient and outpatient markets

Fujifilm to Highlight the Speed of Synapse VX for Mammography and Cardiology, Cloud-Native Architecture and AI-Driven Workflows at RSNA 2024

Advancements across multiple modalities deliver state-of-the-art imaging, improve clinical workflows and enhance patient outcomes Advancements across multiple modalities deliver state-of-the-art imaging, improve clinical workflows and enhance patient outcomes

Fujifilm to Debut Several New Leading-Edge Medical Innovations at the RSNA 2024 Conference

Celebration also includes achieving EMA regulatory issuance of GMP certification at the site Celebration also includes achieving EMA regulatory issuance of GMP certification at the site

FUJIFILM Diosynth Biotechnologies Celebrates the Expansion Completion at its California Cell Therapy Facility

Explore the depths of ultrasound for early diagnosis. RATINGEN, Germany, Nov. 09, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe is proud to launch the next stage of DeepInsight, an innovative ultrasound technology that supports early and accurate diagnosis, treatment, and follow-up management for imaging professionals.

New DeepInsight ‘the next stage' by FUJIFILM

FUJIY's fiscal second-quarter revenues gain from strong sales in the Imaging and Electronics segments, along with favorable exchange rates.

FUJIFILM's Earnings Decline in Q2, Revenues Increase Y/Y

Pioneering a global modular network for facility design and drug production Pioneering a global modular network for facility design and drug production

FUJIFILM Diosynth Biotechnologies Launches First Phase of Global CDMO Ecosystem Expansion

Software is designed to address long-standing pain points of MRI with new deep learning reconstruction, artifact and motion correction technologies Software is designed to address long-standing pain points of MRI with new deep learning reconstruction, artifact and motion correction technologies

Fujifilm Launches New ECHELON Synergy 1.5T MRI System Software with AI Powered Workflow Enhancements

HANOVER PARK, ILL., Oct. 22, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation, Graphic Communication Division, today released the following statement from Hidetoshi (Toshi) Kino regarding the United States International Trade Commission (ITC) final determination on antidumping (AD) and countervailing duties (CVD) on imports of aluminum lithographic printing plates from Japan and China:

Fujifilm Statement on International Trade Commission (ITC) Final Determination on Proposed Duties on Aluminum Lithographic Printing Plates

The lightest model in the current X Series lineup, new camera designed for content creators on the go The lightest model in the current X Series lineup, new camera designed for content creators on the go

Light in Weight, Rich in Features: Fujifilm Introduces FUJIFILM X-M5 Mirrorless Digital Camera

VALHALLA, N.Y., Oct. 14, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation today announces the launch of its FUJINON XF500mmF5.6 R LM OIS WR lens (XF500mmF5.6).

Super-Telephoto Excellence: Fujifilm Announces FUJINON XF500mmF5.6 R LM OIS WR

NEW YORK--(BUSINESS WIRE)-- #Apple--B&H is pleased to announce the new FUJIFILM XM5 vlogging camera, S XF 16-55mm f/2.8 R LM WR II lens for the XM5, and XF 500mm f/5.6 R LM OIS WR Super Telephoto Lens. The latest additions to the brand's renowned X Series provide powerful, lightweight options for those who live on the go. The Fujifilm X-M5 sports a compact build like the X-T50 and the X100VI, making it the smallest X Series body to date but mighty in capabilities. Ideal for novice creators, the came.

FUJIFILM Unveils X-M5 Mirrorless Camera and XF 16-55mm F2.8 R LM WR II Lens; YouTube First Look Video, X-M5 Camera, XF 16-55mm F2.8 II Lens Preorder at B&H Photo

FUJIFILM Holdings Corporation FUJIY has announced a ¥20 billion investment to bolster its semiconductor materials business in Japan. FUJIFILM Electronic Materials Co., Ltd.

FUJIY Boosts Semiconductor Materials Business With 20B Yen Investment

VALHALLA, N.Y., Oct. 02, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Holdings America Corporation, and its Americas subsidiaries, today announced a $250,000 donation to the American Red Cross to support the multi-state relief efforts for those affected by the catastrophic damage of Hurricane Helene.

Fujifilm Donates $250,000 to American Red Cross for Hurricane Helene Relief

SANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, today announced further expansion of its product portfolio and enhanced services through the alignment of specific commercial operations with its sister company, FUJIFILM Wako Chemicals U.S.A., Corp. (FUJIFILM Wako Chemicals). Effective October 1, 2024, products from three divisions within the FUJIFILM Wako Ch.

FUJIFILM Irvine Scientific Adds Key Products to Its Life Sciences Portfolio from FUJIFILM Wako Chemicals U.S.A.

HANOVER PARK, ILL, Sept. 23, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation, Graphic Communication Division, today released the following statement from Hidetoshi (Toshi) Kino, general manager, Graphic Communication Division, FUJIFILM North America Corporation, regarding the U.S. Department of Commerce (DOC) final calculation on the size of the antidumping (AD) and countervailing duties (CVD) on imports of aluminum lithographic printing plates from Japan and China:

Fujifilm Statement on Department of Commerce's Calculation of Proposed Duties on Aluminum Lithographic Printing Plates

Free Event in Austin, Texas Offers Opportunities for Hands-on Interaction with the Latest Camera and Lens Gear, Workshops, Photowalks, Networking and More Free Event in Austin, Texas Offers Opportunities for Hands-on Interaction with the Latest Camera and Lens Gear, Workshops, Photowalks, Networking and More

Fujifilm Celebrates the Art of Creative Storytelling with its Second Annual Create With Us Event

SANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the development of Oceo Rover, a first-of-its-kind* single-use technology system, that enables manufacturers of biopharmaceuticals to improve bioprocessing workflows by automating and simplifying the hydration of media, feeds, and buffers. The automated Oce.

FUJIFILM Irvine Scientific Develops Oceo Rover: The First Automated Single-Use Hydration System for Media and Buffers

VALHALLA, N.Y., Sept. 12, 2024 (GLOBE NEWSWIRE) -- The FUJIFILM INSTAX® brand is sponsoring a series of global breakdancing (breaking) competitions through its ongoing strategic partnership with Undisputed, a global breaking competition series that was established in 2014 by a joint initiative of some of the world's leading breaking events, judges, and competitors. Top breakers from all over the world will bring their best moves and unique styles to the Los Angeles area for the FUJIFILM INSTAX™ Undisputed competition, where live audiences will witness incredible action as competitors go head-to-head. The latest competition/exhibition is scheduled for September 22, 2024, at Thunder Studios in Long Beach, California.

Fujifilm and Undisputed Announce Los Angeles Area Competition Supporting the Culture and Community of Breaking

MADISON, Wis., Sept. 10, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Cellular Dynamics, a leading global developer and manufacturer of human induced pluripotent stem cells (iPSCs) today announces the global commercial launch of its human iPSC-derived iCell® Sensory Neurons for scientists engaged in neuroscience research, drug discovery of novel pain medications, and analysis of neurotoxicity side effects. FUJIFILM Cellular Dynamics will present iCell Sensory Neurons and other key products in its market-leading neuroscience portfolio at the Society for Neuroscience annual conference in Chicago (booth #464) from October 5-9, 2024 and the Annual Pain Therapeutics Summit in Boston from October 28-29, 2024.

FUJIFILM Cellular Dynamics Introduces Human iPSC-derived Sensory Neurons to Advance Pain Research

Company signs Marco Technologies as first dealer in U.S. to sell select APEOS A3/A4 and REVORIA Production Print solutions Company signs Marco Technologies as first dealer in U.S. to sell select APEOS A3/A4 and REVORIA Production Print solutions

Fujifilm Partners with Marco Technologies to Expand U.S. Office and Production Print Solutions and Services Market

RATINGEN, Germany, Sept. 06, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is excited to announce the compatibility between the high-end Ultrasound system ARIETTA 750 FF ENDO and the ultrasound endoscopes (EG-580UR, EG-580UT, and EG-740UT) as well as the linear ultrasound bronchoscope EB-530US. This allows physicians to fully utilize the benefits of FUJIFILM ultrasound endoscopes and bronchoscopes during diagnostic and therapeutic procedures.

FUJIFILM Healthcare Europe announces ARIETTA 750 FF ENDO compatibility with FUJIFILM ultrasound endoscopes and endobronchial ultrasound scope

RATINGEN, Germany, Sept. 04, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is proud to announce the launch of its eagerly anticipated standardised Basic Colonoscopy Training Course in 16 countries across the Growth Emerging Markets (GEM) region. This new course aims to provide healthcare professionals in different regions with the same high quality learning experience.

News for FUJIFILM Holdings Corp Stock (FUJIY)